Objectives:The primary objective of this study was to investigate whether dexmedetomidine could potentiate the analgesic efficacy of ropivacaine, when added to ropivacaine for wound infiltration in patients undergoing open gastrectomy.Methods:Fifty patients scheduled for open gastrectomy were divided into 2 equal groups that were received wound infiltration using 20 mL 0.3% ropivacaine plus 2 mL normal saline (group R) or 20 mL 0.3% ropivacaine plus 2 mL 1.0 μg/kg dexmedetomidine (group DR). Visual analogue scale (VAS) pain score, patient-controlled analgesia (PCA) pump press number, sufentanil consumption, postoperative nausea and vomiting (PONV), and wound healing score were recorded.Results:The VAS pain score were comparable between the 2 groups at the observation time points (P > .05), PCA pump press number and sufentanil consumption were higher in group R than that in group DR at 0 to 2, 2 to 4, 4 to 6 time intervals (P < .05) except for 6 to 8, 8 to 10, 10 to 12 time intervals (P > .05), meanwhile, the 24 hours total sufentanil consumption was also higher in group R than that in group DR (90.4 ± 20.5 vs 79.2 ± 9.4) (P < .05), there were no significant differences in PONV and wound healing score between the 2 groups (P > .05).Conclusions:Dexmedetomidine as an adjuvant to ropivacaine for wound infiltration promoted the analgesic efficacy of ropivacaine, reduced sufentanil consumption, and had no effect on wound healing; it could be as an ideal adjuvant which could potentiate the analgesic efficacy of local anesthetics.
Repetitive intracutaneous injections with local anesthetics and steroids along with standard treatment significantly reduce the duration of pain and herpetic eruption and incidence of PHN.
Intracutaneous sterile water injection (ISWI) is used for relief of low back pain
during labor, acute attacks of urolithiasis, chronic neck and shoulder pain following
whiplash injuries, and chronic myofascial pain syndrome. We conducted a randomized,
double-blinded, placebo-controlled trial to evaluate the effect of ISWI for relief of
acute low back pain (aLBP). A total of 68 patients (41 females and 27 males) between
18 and 55 years old experiencing aLBP with moderate to severe pain (scores ≥5 on an
11-point visual analogue scale [VAS]) were recruited and randomly assigned to receive
either ISWIs (n=34) or intracutaneous isotonic saline injections (placebo treatment;
n=34). The primary outcome was improvement in pain intensity using the VAS at 10, 45,
and 90 min and 1 day after treatment. The secondary outcome was functional
improvement, which was assessed using the Patient-Specific Functional Scale (PSFS) 1
day after treatment. The mean VAS score was significantly lower in the ISWI group
than in the control group at 10, 45, and 90 min, and 1 day after injection
(P<0.05, t-test). The mean increment in PSFS score of the ISWI
group was 2.9±2.2 1 day after treatment, while that in the control group was 0.9±2.2.
Our study showed that ISWI was effective for relieving pain and improving function in
aLBP patients at short-term follow-up. ISWI might be an alternative treatment for
aLBP patients, especially in areas where medications are not available, as well as in
specific patients (e.g., those who are pregnant or have asthma), who are unable to
receive medications or other forms of analgesia because of side effects.
Clinically, preoperative anxiety adversely affected postoperative hyperalgesia. As stress-induced glucocorticoids (GCs) were reported to sensitize the activation of microglia, the present study investigated whether and how GCs and microglia played in the process of preoperative anxiety-induced postoperative hyperalgesia. The study used an animal model that exposed rats to single prolonged stress (SPS) procedure to induce preoperative anxiety-like behaviors 24 h before the plantar incisional surgery. Behavioral testing revealed that preoperative SPS enhanced the mechanical allodynia induced by plantar incision. SPS was also found to induce elevated circulating corticosterone levels, potentiate the activation of spinal microglia, and increase the expression of spinal proinflammatory cytokines. Inhibition of microglia by pretreatment with minocycline attenuated the SPS-enhanced mechanical allodynia, and this was accompanied by decreased activation of spinal microglia and expression of proinflammatory cytokines. Another experiment was conducted by administering RU486, the GC receptor (GR) antagonist, to rats. The results showed that RU486 suppressed SPS-induced and SPS-potentiated proinflammatory activation of spinal microglia and revealed analgesic effects. Together, these data indicated that inhibition of stress-induced GR activation attenuated the preoperative anxiety-induced exacerbation of postoperative pain, and the suppression of spinal microglia activation may underlie this anti-hyperalgesia effect. Pending further studies, these findings suggested that GR and spinal microglia may play important roles in the development of preoperative anxiety-induced postoperative hyperalgesia and may serve as novel targets to prevent this phenomenon.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.